InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-10.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Sofinnova Venture Partners X, L.P.. Director active across 3 companies, notably Vera Therapeutics, Inc.. Aggregated, 9 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €19.9m. History available since 10 February 2022. The latest transaction was disclosed on 6 February 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
285,714 shares@ US$7.0034.6% of flowClass A Common StockSEC:0001104659-23-014661:0
Ideal exit: 3 Nov 2023 (T+270)
500,000 shares@ US$30.00100.0% of flowCommon StockSEC:0001104659-22-091184:0
Ideal exit: 8 May 2023 (T+270)
266,666 shares@ US$15.000.097% mcap100.0% of flowClass A Common StockSEC:0001104659-22-023301:0
Ideal exit: 7 Nov 2022 (T+270)
5,248,949 sharesCommon StockSEC:0001209191-22-003197
5,248,949 sharesCommon StockSEC:0001209191-22-003197:0
3,401,544 sharesCommon StockSEC:0001104659-21-089440:0
3,401,544 sharesCommon StockSEC:0001104659-21-089440
2,187,504 sharesClass A Common StockSEC:0001209191-21-033818
2,187,504 sharesClass A Common StockSEC:0001209191-21-033818:0
9 of 9 declarations
About Sofinnova Venture Partners X, L.P.
Sofinnova Venture Partners X, L.P. is a director and insider, primarily associated with Vera Therapeutics, Inc.
